SUZHOU SUNCADIA BIOPHARMACEUTICALS CO., LTD.;JIANGSU HENGRUI MEDICINE CO., LTD.
发明人:
ZOU, JIANJUN,邹建军,鄒建軍,YANG, QING,杨清,楊清
申请号：
TW107140820
公开号：
TW201922292A
申请日:
2018.11.16
申请国别(地区):
TW
年份:
2019
代理人:
摘要：
The present invention provides to uses of immunotherapy agents, nucleoside antimetabolites combined with platinum in the preparation of drugs for treating tumor. Specifically, the present invention provides to uses of PD-1 antibody, gemcitabine combined with cisplatin in the preparation of drugs for treating nasopharyngeal carcinoma.本發明提供了免疫治療劑、核苷類抗代謝物和鉑類聯合在製備治療腫瘤的藥物中的用途。具體而言，本發明提供了PD-1抗體、吉西他濱和和順鉑在製備治療鼻咽癌的藥物中的用途。
